蛋白质纳米载体:用于癌症治疗和成像的向治疗
Reyhan Dilsu Colpan1, Neil R Thomas2, Lyudmila Turyanska3
1Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.
Cancers
|March 14, 2026
概括
基于蛋白质的纳米载体为向癌症提供生物相容的解决方案. 本综述强调了蛋白质纳米载体的进步,以改善瘤学治疗和诊断.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 基于蛋白质的纳米载体越来越被认为是癌症治疗药物.
- 它们的生物相容性,生物降解性和功能化潜力是其关键优势.
- 独特的特性,如自组装和低免疫性,适合瘤学.
研究的目的:
- 对针对癌症的基于蛋白质的纳米载体的最新进展进行审查.
- 强调受体特定向,成像集成和临床前模型.
- 为癌症治疗中蛋白质纳米载体的未来方向提供见解.
主要方法:
- 关于基于蛋白质的纳米载体的最近研究的文献综述.
- 专注于白蛋白,脂蛋白,费里丁,病毒蛋白囊,纤维素和丝蛋白.
- 对准机制,成像方法和临床前模型的分析.
主要成果:
- 总结了各种蛋白质纳米载体类型的进展.
- 详细的受体特定准策略和成像集成.
- 强调了先进的临床前模型对翻译的重要性.
结论:
- 基于蛋白质的纳米载体在向癌症治疗中显示出显著的前景.
- 对先进的临床前模型的进一步研究对于临床转化至关重要.
- 未来的方向包括优化准和成像,以增强瘤学应用.
更多相关视频
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
3.2K
07:54Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
8.8K
相关概念视频
Targeted Cancer Therapies
1.7K
1.7K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Site-Targeted Drug Delivery Systems: Polymeric Carriers
79
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
79
Modified-Release Drug Delivery Systems: Site-Targeted
70
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
70
